Przegla̧d epidemiologiczny
-
In the last years, attention has been paid to Zika virus (ZIKV) infection, the emerging vector-borne disease. It is responsible for major outbreaks in Africa, Asia and, more recently, in previously infection-naïve territories of the Pacific area, South America and Caribbean. The etiology, epidemiology, transmission, and clinical manifestations of ZIKV disease are discussed, along with the diagnostic possibilities in the aim to assessing the risk of its introduction to Poland. ⋯ As the awareness of the infection risk will increase among medical staff and travelers, the number of suspected cases of travel-related ZIKV infections may rise in Poland. Medical staff should be informed where and how to report such cases. Thorough surveillance, adequate assessment of possible threats, action plans, rapid and effective intervention development, spread of up to date information of ZIKV, as well as other emerging or re-emerging infectious pathogens can play a key role in guaranteeing population health.
-
Patients in the intensive care units (ICU) are exposed to many factors that may cause hospital acquired pneumonia (HAP), a particular type of which is ventilator-associated pneumonia (VAP). The specific risk factors for developing VAP affect patients already on the day of their admission to a unit and are associated with their underlying diseases and invasive medical procedures, which they undergo. The aim of this study was to evaluate the risk factors for VAP associated with a patient and the used invasive treatment. ⋯ In the analyzed unit, 58 cases of VAP were detected in patents who underwent mechanical ventilation. Infections were more common among men (43 cases, that is 6%) than in women (15 cases, that is 3%). Mechanical ventilation longer than 20 days was a major determinant of VAP (p < 0.001). Patient's underlying diseases (which are the reason for patient's admission to a unit) had an impact on the incidence of VAP, and the most important of them are: multiple trauma (20 cases of VAP per 217 patients (9.2% incidence)), sepsis (3 cases of VAP per 31 patients (9.7% incidence)), central nervous system disease (10 cases of VAP per 124 patients (8.1% incidence)), endocrine system (1 case of VAP per 12 patients (8.3% incidence)), respiratory diseases (11 cases of VAP per 168 patients (6.5% incidence)). Invasive medical procedures performed in the patients' respiratory tract were significant risk factors (p < 0.001) for developing VAP: reintubation (R=0.271), tracheostomy (R=0.309) and bronchoscopy (R=0.316). In the period from 2010 to 2014 VAP incidence was 4.7% and incidence density per 1000 ventilation-days was 10.5 and the mortality rate with VAP was 32.8%. The most common etiological factors of VAP were Acinetobacter Baumannie (21 isolates, that is 36.4%), Pseudomonas aeruginosa (8 isolates, that is 13.8%), Escherichia coli (7 isolates, that is 12%).